0001799191-22-000013.txt : 20221117 0001799191-22-000013.hdr.sgml : 20221117 20221117173053 ACCESSION NUMBER: 0001799191-22-000013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221115 FILED AS OF DATE: 20221117 DATE AS OF CHANGE: 20221117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Miller Matthew P CENTRAL INDEX KEY: 0001915822 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39248 FILM NUMBER: 221399732 MAIL ADDRESS: STREET 1: C/O THE ONCOLOGY INSTITUTE OF HOPE STREET 2: 18000 STUDEBAKER ROAD, SUITE 800 CITY: CERRITOS STATE: CA ZIP: 90703 FORMER NAME: FORMER CONFORMED NAME: Miller Matthew Seth Porter DATE OF NAME CHANGE: 20220308 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncology Institute, Inc. CENTRAL INDEX KEY: 0001799191 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 18000 STUDEBAKER RD STREET 2: SUITE 800 CITY: CERRITOS STATE: CA ZIP: 90703 BUSINESS PHONE: 562-735-3226 MAIL ADDRESS: STREET 1: 18000 STUDEBAKER RD STREET 2: SUITE 800 CITY: CERRITOS STATE: CA ZIP: 90703 FORMER COMPANY: FORMER CONFORMED NAME: DFP HEALTHCARE ACQUISITIONS CORP. DATE OF NAME CHANGE: 20200108 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2022-11-15 0 0001799191 Oncology Institute, Inc. TOI 0001915822 Miller Matthew P C/O THE ONCOLOGY INSTITUTE INC. 18000 STUDEBAKER RD, SUITE 800 CERRITOS CA 90703 0 1 0 0 Chief Operating Officer Common Stock 2022-11-15 4 D 0 577 2.0277 D 78034 D The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement. Price is the volume weighted average selling price of all sales by the Reporting Person on November 15, 2022 within a one-dollar range. Actual prices ranged from $2.022 to $2.028. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. By: Mark Hueppelsheuser For: Matt Miller 2022-11-17